Skip to content
Advanced Analysis
Free Trading Signals
Real-Time Alerts
Data & Analytics

Glaxosmithkline Consumer Nigeria Plc (NGX: GLAXOSMITH) | Share Price

Nigel Firth
Nigel Frith trader
Updated 20 May 2024

Glaxosmithkline Consumer Nigeria Plc is a Nigeria-based research-based pharmaceutical and healthcare company listed on the Nigerian Stock Exchange (NGX).

 

Overview of Glaxosmithkline Consumer Nigeria Plc

Glaxosmithkline Consumer Nigeria Plc manufactures and markets a range of consumer healthcare and pharmaceutical products for the treatment of several illnesses and conditions like asthma, HIV/AIDS, malaria, depression, migraines, diabetes, heart failure, digestive ailments, cancer, hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza and cervical cancer..

Today, Glaxosmithkline Consumer Nigeria Plc’s portfolio of products and services are diversified in more sectors of the Health Care value chain and its operating segments include Pharmaceuticals and Consumer Healthcare. The Consumer Healthcare segment includes oral care, over-the-counter (OTC) medicines and nutritional healthcare. The Pharmaceuticals segment consists of antibacterial, vaccines and prescription drugs. The company’s manufacturing unit is Global Manufacturing and Supply (GMS) which is located in Agbara, Ogun State.

The history of Glaxosmithkline Consumer Nigeria Plc goes back to 1971 when it was founded but known as Beecham Limited.

Glaxosmithkline Consumer Nigeria Plc has its head offices at GSK House, No. 1, Industrial Avenue, Ilupeju, Ikeja, Nigeria.

The current Managing Director of Glaxosmithkline Consumer Nigeria Plc is Kunle Oyelana.

Glaxosmithkline Consumer Nigeria Plc’s equity stocks are for sale online on the Nigerian Stock Exchange (NGX) under the stock symbol GLAXOSMITH.

Glaxosmithkline Consumer Nigeria Plc forms part of the Biotechnology & Drugs Industry and the Health Care Sector of the Nigerian Stock Exchange (NGX).

OPEN DEMO TRADING ACCOUNT YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
Glaxosmithkline Consumer Nigeria Plc

Glaxosmithkline Consumer Nigeria Plc Stock Performance

The current price for Glaxosmithkline Consumer Nigeria Plc stocks on the Nigerian Stock Exchange (NGX) is 6.35 Nigerian Naira (NGN).

An analysis of financial data of Glaxosmithkline Consumer Nigeria Plc showed that the company has a total market capitalisation of 7.59 Billion NGN, with a Price/Earning ratio of 10.95 and earnings per share of 0.58 NGN. A total of 1.2 Billion shares were outstanding.

With an increase of earnings per share and reliable profits over a period, investors who want to buy or sell Glaxosmithkline Consumer Nigeria Plc stocks can look forward to more profitable dividends and earnings in times to come.

According to an analysis on the live chart of Glaxosmithkline Consumer Nigeria Plc, analysts forecast further improved performance for the Health Care sector with market share growing as trading volumes increase.

Glaxo Smithkline

Highlights of Glaxosmithkline Consumer Nigeria Plc in 2021

Glaxosmithkline Consumer Nigeria Plc started the current financial year (2021) with a share price of 6.90 Nigerian Naira (NGN) on the Nigerian Stock Exchange (NGX), and it has lost 7.97 % in value on its price valuation, ranking 124th on the NGX with its year-to-date performance.

Glaxosmithkline Consumer Nigeria Plc is currently the 70th most-traded stock on the NGX and it has experienced a total trading volume of more than 17.9 million shares, which were finalised in 1,266 deals and were valued at a total of 111 million Nigerian Naira (NGN) over the recent three month period from August to November 2021, with an average of 284,102 shares in each trading session.

During the same period a volume high of 2.01 million was achieved on 21 September.

Glaxo Smithkline - How To Trade

How to buy Glaxosmithkline Consumer Nigeria Plc stocks – Step by Step

The stock market is one of the most attractive financial markets that sees millions of retail investors and traders participating daily. To buy, sell or trade Glaxosmithkline Consumer Nigeria Plc stocks on the Nigerian Stock Exchange (NGX), traders and investors can follow a few simple steps:

  1. Find the share that you want to buy, in this case, “GLAXOSMITH”.
  2. Select a forex broker that offers access to the Nigerian Stock Exchange (NGX).
  3. Review the broker's trading conditions, fees, deposit and withdrawal methods, trading platform, customer support, regulation, and other components to ensure that they are aligned with your trading plan.
  4. Open a live trading account with the broker by completing the online application form and providing the necessary documentation to verify the trading account.
  5. Once your account has been activated, you are ready to make your first share purchase through the broker.
  6. From here you can start to build and diversify your portfolio by buying more shares.

FAQs

The Nigerian Stock Exchange (NGX) (officially the Nigerian Exchange Group) is a leading integrated market organisation in Africa servicing the continent’s largest economy, that of Nigeria. The Exchange provides capital access to companies that seek to take advantage of the financial markets to fund their business expansion. The NGX also provides its collection of domestic, regional, and international investors with an array of regulated securities to achieve their investment objectives.

The NGX publishes the benchmark, value-weighted All-Share Index (ASI), formulated in January 1984 with a base value of 100 and which tracks the general market movement of all listed equities on the Exchange.

The NGX30 and NGX50 are additional indices that track the top 30 and 50 companies in terms of market capitalization and liquidity respectively. Only fully paid-up common shares weighted by adjusted market capitalization are admitted to these indices.

In March 2021, the Nigerian Stock Exchange was transformed into a shareholder-owned, profit making entity, the Nigerian Exchange Group Plc, when it was demutualised from a member-owned not-for-profit entity.

People Who Read This Also Read:

Nigel Firth
Nigel Frith trader
Nigel has been in the regulated financial services industry for nearly a decade, has previously owned a financial brokerage and has written many times for sites relating to personal finance and trading.